Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet prostaglandin production and its implications

J B Smith, C M Ingerman, M J Silver

    Advances in Prostaglandin and Thromboxane Research
    |January 1, 1976
    PubMed
    Summary

    Platelet aggregation is mediated by prostaglandin production when induced by arachidonic acid, but not by ADP. Synergistic effects of ADP with other agents facilitate platelet aggregation, crucial for hemostasis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Herpes zoster and internal malignancy.

    Southern medical journal·1995
    Same author

    Multiple collagenomas in a patient with Down syndrome.

    Journal of the American Academy of Dermatology·1995
    Same author

    Factors that exacerbate linear IgA disease.

    Journal of the American Academy of Dermatology·1995
    Same author

    Phorbol esters downregulate expression of the sodium/calcium exchanger in renal epithelial cells.

    The American journal of physiology·1995
    Same author

    Glucocorticoid-attenuated response genes encode intercellular mediators, including a new C-X-C chemokine.

    The Journal of biological chemistry·1995
    Same author

    Femoral neck stress fractures in children and adolescents.

    Journal of pediatric orthopedics·1995

    Area of Science:

    • Biochemistry
    • Hematology
    • Pharmacology

    Background:

    • Platelet aggregation is a critical process in hemostasis.
    • Arachidonic acid and adenosine diphosphate (ADP) are key agonists involved in platelet activation.
    • Prostaglandins play a role in platelet function.

    Purpose of the Study:

    • To investigate the role of prostaglandin production in platelet aggregation induced by arachidonic acid.
    • To differentiate the mechanisms of platelet aggregation induced by arachidonic acid and ADP.
    • To elucidate the synergistic interactions between different platelet agonists and cofactors.

    Main Methods:

    • Platelet aggregation assays were performed using washed human platelets.
    • The effects of aspirin and indomethacin on platelet shape change and aggregation were assessed.
    • The role of fibrinogen as a cofactor in platelet aggregation was examined.
    • Synergistic effects of various agonists (arachidonic acid, synthetic prostaglandin, ADP) were investigated.

    Main Results:

    • Aspirin and indomethacin inhibited platelet aggregation induced by arachidonic acid, confirming prostaglandin involvement.
    • Prostaglandin endoperoxides (PGG2/PGH2) and a synthetic prostaglandin (Wy-17,186) mimicked arachidonic acid's effects.
    • Neither aspirin nor indomethacin affected platelet aggregation induced by ADP, indicating a non-prostaglandin pathway.
    • Fibrinogen is required for aggregation by individual agonists, but ADP showed synergism with arachidonic acid or Wy-17,186 in its absence.
    • Collagen-induced platelet degranulation released ADP and prostaglandin endoperoxides, enabling aggregation without added fibrinogen.

    Conclusions:

    • Platelet aggregation induced by arachidonic acid is mediated by prostaglandin production.
    • ADP-induced platelet aggregation involves a separate pathway independent of prostaglandins.
    • Synergistic interactions between prostaglandin endoperoxides, ADP, and fibrinogen are essential for normal hemostasis.

    Related Experiment Videos